ConductScience.org, home

Paper19436622

Fludarabine in the treatment of chronic lymphocytic leukemia: a review.

Ricci F and 3 others. Ther Clin Risk Manag, 2009. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Fludarabine in the treatment of chronic lymphocytic leukemia: a review. Papers, record 19436622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19436622

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fludarabine in the treatment of chronic lymphocytic leukemia: a review.
PubMed
Journal
Ther Clin Risk Manag
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2023-11-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ricci FFrancesca
2Tedeschi AAlessandra
3Morra EEnrica
4Montillo MMarco

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114586480Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.Leukemia2004https://conductscience.org/library/papers/14586480PubMed
216131571Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.Blood2005https://conductscience.org/library/papers/16131571PubMed
33478543Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.Leukemia1987https://conductscience.org/library/papers/3478543PubMed
415071604
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Leukemia2004https://conductscience.org/library/papers/15071604PubMed
510334546Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.J Clin Oncol1999https://conductscience.org/library/papers/10334546PubMed
615197800Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.Cancer2004https://conductscience.org/library/papers/15197800PubMed
73807892Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs.Mol Pharmacol1987https://conductscience.org/library/papers/3807892PubMed
81675805Metabolism and action of purine nucleoside analogs.Pharmacol Ther1991https://conductscience.org/library/papers/1675805PubMed
911436116Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.Bone Marrow Transplant2001https://conductscience.org/library/papers/11436116PubMed
1015117764Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses.Blood2005https://conductscience.org/library/papers/15117764PubMed
1110779422Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.Blood2000https://conductscience.org/library/papers/10779422PubMed
1211114313Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.N Engl J Med2000https://conductscience.org/library/papers/11114313PubMed
139753416First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.Eur J Haematol1998https://conductscience.org/library/papers/9753416PubMed
1419704063Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.J Clin Oncol2009https://conductscience.org/library/papers/19704063PubMed
159694704Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.Blood1998https://conductscience.org/library/papers/9694704PubMed
1611529853Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.Br J Haematol2001https://conductscience.org/library/papers/11529853PubMed
1718710390High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.Br J Haematol2008https://conductscience.org/library/papers/18710390PubMed
183050447Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.Mol Pharmacol1988https://conductscience.org/library/papers/3050447PubMed
1911920267The bioavailability of oral fludarabine phosphate is unaffected by food.Hematol J2001https://conductscience.org/library/papers/11920267PubMed
207042080Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.Cancer Res1982https://conductscience.org/library/papers/7042080PubMed

See all 110 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42615647Activity of MMV Pandemic Response Box compounds against Mycobacterium ulcerans viability and mycolactone production.Microbiol Spectr2026https://conductscience.org/library/papers/42615647PubMed
41697742PDGFRβ signaling restrains myocyte function to limit the regenerative capacity of skeletal muscle.J Clin Invest2026https://conductscience.org/library/papers/41697742PubMed
40649226Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions.Molecules2025https://conductscience.org/library/papers/40649226PubMed
404305525'-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5'-Functionalized Nucleosides with Biological Potential.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430552PubMed
40336064Fludarabine attenuates inflammation and dysregulated autophagy in alveolar macrophages via inhibition of STAT1/IRF1 pathway.Lab Anim Res2025https://conductscience.org/library/papers/40336064PubMed
401769693'-O-β-Glucosylation of nucleoside analogues using a promiscuous bacterial glycosyltransferase.RSC Chem Biol2025https://conductscience.org/library/papers/40176969PubMed
38893081Skin Malignancies Due to Anti-Cancer Therapies.Cancers (Basel)2024https://conductscience.org/library/papers/38893081PubMed
38775157BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia.JCI Insight2024https://conductscience.org/library/papers/38775157PubMed
38279745Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation.Curr Top Med Chem2024https://conductscience.org/library/papers/38279745PubMed
38140557The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic.Viruses2023https://conductscience.org/library/papers/38140557PubMed
37397557Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.Genes Dis2023https://conductscience.org/library/papers/37397557PubMed
37226709Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia.Haematologica2023https://conductscience.org/library/papers/37226709PubMed
37002214Age-dependent Pdgfrβ signaling drives adipocyte progenitor dysfunction to alter the beige adipogenic niche in male mice.Nat Commun2023https://conductscience.org/library/papers/37002214PubMed
35358273Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.PLoS One2022https://conductscience.org/library/papers/35358273PubMed
35323219Combined Effects of Fludarabine and Interferon Alpha on Autophagy Regulation Define the Phase of Cell Survival and Promotes Responses in LLC-MK2 and K562 Cells.Med Sci (Basel)2022https://conductscience.org/library/papers/35323219PubMed
35280986Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.Front Immunol2022https://conductscience.org/library/papers/35280986PubMed
33657175Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/33657175PubMed
32560115Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii.Pathogens2020https://conductscience.org/library/papers/32560115PubMed
29789639Fludarabine and neurotoxicity in engineered T-cell therapy.Gene Ther2018https://conductscience.org/library/papers/29789639PubMed
29317636The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis.Cell Death Dis2018https://conductscience.org/library/papers/29317636PubMed

See all 36 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19436622

GET https://conductscience.org/api/papers/v1/19436622/references?page=2